Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG
NCT ID: NCT03849196
Last Updated: 2019-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
168 participants
INTERVENTIONAL
2017-07-31
2018-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl
NCT02980562
Comparison of Bowel Cleansing Methods for Colonoscopy in Hospitalized Patients
NCT01528098
Evaluation of a Mixed Bowel Prep (2L PEG + Bisacodyl) Versus PEG With Ascorbate
NCT01509131
Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy
NCT01533090
Efficacy of 2-Liter Mixed Preparation With Bisacodyl Plus Polyethylene Glycol and 4-Liter Polyethylene Glycol for Colon Cleansing in Patients With Prior History of Colorectal Resection
NCT01887158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Exclusion criteria: patients with a history of gastrointestinal tract surgery, inflammatory bowel disease, severe active colitis, underlying chronic kidney disease, or pregnancy.
Outcome measures: the Boston Bowel Preparation Scale (BBPS)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2L PEG-Asc
2L PEG-Asc for bowel preparation
2L PEG-Asc
PEG-Asc powder
1L PEG-Asc & 'Bisacodyl 10Mg Suppository
1L PEG-Asc with 'Bisacodyl 10Mg Suppository for bowel preparation
Bisacodyl 10Mg Suppository
bisacodyl 10 mg suppository
1L PEG-Asc
PEG-Asc powder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2L PEG-Asc
PEG-Asc powder
Bisacodyl 10Mg Suppository
bisacodyl 10 mg suppository
1L PEG-Asc
PEG-Asc powder
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of inflammatory bowel disease
* History of severe active colitis
* History of chronic kidney disease
* pregnant woman.
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eun Ran Kim
Clinical associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-05-100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.